Marco is a biochemist with a strong expertise in chemical biology. In his PhD thesis he developed novel methods for drug discovery. That was honored by the German Chemical Society with the Klaus Grohe Prize of Medicinal Chemistry. Afterwards he joined the University Chemical Laboratory Cambridge UK, working for the Bill & Melinda Gates Foundation on novel anti-tuberculosis drugs. During his stay at the University of Cambridge Marco was awarded with a prestigious Marie Curie Fellowship of the European Commission for the development of a novel drug class targeting RNA interference.
Marco provides almost a decade of experience in the biotech ecosystem. He initiated or joined several spin-offs from academia, always with a focus of generating a business model for a new technology. Marco shares his expertise. He edited and co-authored several books and articles dealing of novel technologies in drug discovery and development.